SCHEMBL13318577

SCHEMBL13318577

COC(=O)NNC(=O)c1cc(C#N)cc(C)c1NC(=O)c1cc(Br)nn1-c1ncccc1Cl

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 3/20 0.40
▸ PDE4B Q07343 2/20 0.35
▸ PDE4A P27815 1/20 0.35
▸ PDE4C Q08493 1/20 0.35
▸ PDE4D Q08499 1/20 0.35
▸ KMT2A Q03164 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ KCNH2 Q12809 5/20 0.32
▸ GCK P35557 4/20 0.32
▸ MALT1 Q9UDY8 2/20 0.32
▸ GPR6 P46095 2/20 0.32
▸ SLC2A1 P11166 1/20 0.31
▸ SLC2A2 P11168 1/20 0.31
▸ SLC2A3 P11169 1/20 0.31
▸ SLC2A4 P14672 1/20 0.31
▸ PPARG P37231 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12911705 0.92 DHODH (0.41) DHODHPDE4BPDE4APDE4CPDE4D
SCHEMBL120729 0.90 DHODH (0.42) DHODHKMT2AALDH1A1MALT1
SCHEMBL15289892 0.90 DHODH (0.42) DHODHPDE4BPDE4APDE4CPDE4D
SCHEMBL13073077 0.90 DHODH (0.40) DHODHPDE4BPDE4APDE4CPDE4D
Cyantraniliprole SCHEMBL29354965 0.89 DHODH (0.42) DHODHPDE4BPDE4APDE4CPDE4D
Cyantraniliprole SCHEMBL166640 0.89 DHODH (0.42) DHODHPDE4BPDE4APDE4CPDE4D
SCHEMBL12559348 0.89 DHODH (0.40) DHODHPDE4BPDE4APDE4CPDE4D
SCHEMBL30078383 0.89 DHODH (0.41) DHODHPDE4BPDE4APDE4CPDE4D
SCHEMBL563173 0.89 DHODH (0.41) DHODHPDE4BPDE4APDE4CPDE4D
SCHEMBL950199 0.89 DHODH (0.42) DHODHPDE4BPDE4APDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100137314-A1 HARMFUL ORGANISM CONTROL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-03 — — US disclosed
US-20100137314-A1 HARMFUL ORGANISM CONTROL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-03 — — US disclosed
US-20100099692-A1 HARMFUL ORGANISM CONTROL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-22 — — US disclosed
US-20100099692-A1 HARMFUL ORGANISM CONTROL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099692-A1 HARMFUL ORGANISM CONTROL COMPOSITION UQCRC1, UQCRC2, Q6ZSR9 DHODH 277/4885PDE4B 1981/4885PDE4A 2109/4885
US-20100137314-A1 HARMFUL ORGANISM CONTROL COMPOSITION UQCRC2, UQCRC1, UQCRB DHODH 558/4885PDE4B 2099/4885PDE4A 2365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback